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Abstract
Background Among the proposals for joint disease mapping, the shared com-
ponent model has become more popular. Another recent advance to strengthen
inference of disease data has been the extension of purely spatial models to
include time and space-time interaction. Such analyses have additional bene-
fits over purely spatial models. However, only a few proposed spatio-temporal
models could address analysing multiple diseases jointly.
Methods In the proposed model, each component is shared by different
subsets of diseases, spatial and temporal trends are considered for each com-
ponent, and the relative weight of these trends for each component for each
relevant disease can be estimated.
Results We present an application of the proposed method on incidence
rates of seven prevalent cancers in Iran. The effect of the shared components on
the individual cancer types can be identified. Regional and temporal variation
in relative risks is shown.
Conclusions We present a model which combines the benefits of shared-
components with spatio-temporal techniques for multivariate data. We show,
how the model allows to analyse geographical and temporal variation among
diseases beyond previous approaches.
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1 Introduction
Disease mapping is defined as the spatial analysis, estimation and presenta-
tion of disease incidence, prevalence, survival or mortality data. It has seen a
tremendous growth in the last few decades that have led to the use of complex
models enabling the study of possible associations between the disease rates and
spatially varying covariates Lawson et al. (2003, 2000).
However most of the work in the field of disease mapping studies has been
carried out at the univariate level considering spatial modelling of a single dis-
ease. Nevertheless many diseases share common risk factors and it can be
advantageous both from the epidemiological and the statistical point of view to
apply models which combine information from related diseases Knorr-Held and
Best (2001). Therefore, multivariate disease mapping has emerged, which is
defined as the joint modelling of the spatial occurrence of two or more diseases
or health outcomes Assunc¸a˜o and Castro (2004).
Employing this approach we can expect more information is available com-
pared to considering each disease separately. This can lead to benefits like the
ability to highlight shared and divergent geographical patterns of the different
diseases. The precision and efficiency of estimates can be improved, leading
to a better identification of hot-spots for less prevalent diseases and improved
prediction of those diseases. Joint disease models allow to suggest possible risk
factors associated with the diseases, providing stronger and more convincing
evidence for the underlying risk surface. Finally, the understanding of relation-
ships among diseases and ease of interpretation can be increased Knorr-Held
and Best (2001), Dabney and Wakefield (2005), Dreassi (2007), Downing et al.
(2008), Held et al. (2005).
The shared component model has become more popular in recent years and
several types of this model for different data structures have been introduced.
This model is a Bayesian hierarchical latent variable model where the relative
risk of each of the two or more diseases is split into some different spatially
structured latent components. Each component is shared by different subsets of
diseases and the area-specific values of these shared components as well as the
relative contribution (weight) of the component to each relevant disease may be
estimated Dabney and Wakefield (2005), Downing et al. (2008), Mahaki et al.
(2011).
Another recent advance to strengthen inference in the subject of disease
mapping has been the extension of purely spatial models to include time and
also space-time interaction Bernardinelli et al. (1995), Knorr-Held and Besag
(1998), Knorr-Held and Becker (2000), Oleson et al. (2008). Such analyses
may have additional benefits over purely spatial disease mapping. The ability
to study and identify the persistence or systematic evolvement of geographical
patterns over time provides more convincing evidence of true variations than a
single cross-sectional analysis Bernardinelli et al. (1995), Knorr-Held and Besag
(1998), Knorr-Held and Becker (2000). However, only a few proposed spatio-
temporal models could address analysing multiple diseases jointly. There is a
growing need to combine methods for spatial-only and temporal-only analysis of
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multivariate data, to enable simultaneous investigation of spacetime variations
in multiple health outcomes Oleson et al. (2008), Richardson et al. (2006).
In this study we aim to combine the idea of multivariate shared components
with spatio-temporal modelling in a joint disease mapping model. To this end,
each of the shared components in the proposed model considers spatial and
temporal dimensions. Each component is shared between a subset of the diseases
and therefore represents a different latent variable. The model can be applied
for any desired number of diseases, time periods and spatial areas. We focus
on applying this model for incidence rates of seven prevalent cancers in Iran to
explore their spatial and temporal patterns, and to estimate the relative weight
of the four shared component for each cancer in time periods and geographical
areas.
We outline the data, joint spatio-temporal shared component models, as-
signment of prior distributions and finally computation and model comparison
in section 2. We then describe the model comparison results and also estimates
obtained for the best model in the section 3. Finally in section 4, we present
statistical and epidemiological conclusion and discussion.
2 Methods
2.1 Data
Incidence data for seven cancers including esophagus (ICD10 code C15), stom-
ach (C16), bladder (C67), colorectal (C18-C20, C26), lung (C34), prostate (C61)
and breast (C50) cancer in 30 provinces of Iran in 5 years, 2005-2009, were con-
sidered in this analysis. According to the Iran cancer registry reports, these
cancers are amongst the 10 most prevalent cancers in Iran and together account
for approximately 50% of all cancers. The data have been collected and made
available by the Iranian Ministry of Health and Medical Education (Iran Cancer
Registry Report, 2005–2009). Let Yijk be the observed number of incident cases
for cancer type k = 1, . . . , 7, grouped within province i = 1, . . . , 30 and time
period j = 1, . . . , 5. The expected number of cases Eijk in each province and
each year were calculated by multiplying the national crude incidence rate and
the estimate of the province population for the corresponding year. The latter
was based on 2006 census conducted by Statistical Center of Iran.
2.2 Joint Spatio-temporal Shared Component Models
We propose a Bayesian hierarchical model to provide improved estimates of
area and time period-specific cancer relative risks (RR). In this, similarities
and differences in risk profiles of the diseases were captured by the shared and
disease-specific components using a shared component model, with space-time
interactions Downing et al. (2008), Held et al. (2005). As an initial step, it
is convenient to assume that the number of incidences Yijk are conditionally
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independent Poisson random variables:
Yijk|θijk ∼ Poisson(Eijkθijk)
where θijk represent the true, but unknown underlying relative risks. This
Poisson model is widely used for cancer mapping, and arises as an approximation
to the binomial distribution for rare and noninfectious diseases. Then following
Richardson et al. (2006), we modeled the variability of the observed incidence
counts around the relative risks:
log(θijk) = αk + µijk
with αk the intercept for cancer k. The cancers used here are esophagus (k = 1),
stomach (k = 2), bladder (k = 3), colorectal (k = 4), lung (k = 5), prostate
(k = 6) and breast (k = 7) cancers, respectively.
We introduce a spacetime structure on the log scale by considering different
hypotheses on the joint structure of µijk. We consider four variations of the
joint spatio-temporal shared component model to estimate relative risks of the
diseases in space and time. The models differ in their assumption of the space-
time structure and the inclusion or not of a heterogeneity term. We start with
a simple additive decomposition of the shared part without heterogeneity and
space-time interaction terms (model A),
µijk =
4∑
l=1
λliδlk +
4∑
l=1
φljψlk
with λli and φlj with l = 1, 2, 3, 4 represent the spatial and temporal effects
of shared smoking component (l = 1) common to esophagus, stomach, bladder
and lung cancers, overweight and obesity component (l = 2) relevant to esoph-
agus, colorectal, prostate and breast cancers, inadequate fruits and vegetables
consumption (l = 3) for esophagus and stomach cancers and low physical activ-
ity factors (l = 4) common to colorectal and breast cancers respectively which
capture the differential spatial and temporal effects among the relevant cancers.
The unknown parameters δ and ψ are included to allow for different risk gra-
dients of the shared spatial and temporal components for the relevant diseases
and they represent the relative weight of the contribution of the shared terms
to the risk of the relevant cancers, and are set to zero if the component is not
relevant to the specific cancer.
In model B we include cancer-specific heterogeneity ijt to capture possible
variations not explained by the terms included in model A,
µijk =
4∑
l=1
λliδlk +
4∑
l=1
φljψlk + ijk
In model C we add spacetime interaction terms common to all diseases ηij
to model A. The shared space-time interaction effects capture deviations from
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space and time main effects and may highlight space-time clusters of risk,
µijk =
4∑
l=1
λliδlk +
4∑
l=1
φljψlk + ηij
Finally we build Model D by combining models B and C.
µijk =
4∑
l=1
λliδlk +
4∑
l=1
φljψlk + ηij + ijt
2.3 Specification of Priors
In a Bayesian framework prior distributions must be defined on all unknown pa-
rameters, whether fixed or random. We require priors that combine the frame-
work introduced by (Besag et al., 1991) (known as BYM model) to link risk in
space at every time period and time series techniques to link risk in time at every
area. In this study, we assume conditional autoregressive (CAR) normal prior
distribution to capture local dependence in space for the shared spatial random
effects λl = (λl1, . . . , λl30) Oleson et al. (2008), Richardson et al. (2006), i.e.,
λl ∼ N(0,Q−1). The neighbourhood matrix Q is defined by contiguity. Simi-
larly, for the shared temporal effects φj , in order to capture local dependence in
time, we use first order random walk priors, that is, the one dimensional version
of the CAR normal prior distribution, where the neighbourhood matrix R is
defined by the temporal neighbours of period j as periods j1 and j + 1. near 1
and none of them were significant. For the disease specific heterogeneity terms,
we assign a zero-mean multivariate normal distribution with covariance matrix
Σ to allow for correlation between the relevant diseases in each spacetime unit.
For the disease specific intercepts αk we use a noninformative flat prior and
for the logarithm of spatial and temporal scale parameters (log(δ) and log(ψ))
we assign multivariate normal distribution with mean 0 and variance 5.
For all the precision parameters of the spatial and temporal CAR priors we
follow Wakefield et al. (2000) and use weakly informative independent hyper-
prior Gamma(0.5, 0.0005) distributions. The inverse of the covariance matrix Σ
is given a Wishart(S,7) prior distribution, where the scale parameter S is a 7-
dimensional identity matrix. There are various choices of prior distributions for
the space-time interaction effects. In the present study, we only have 5 periods;
too few to show any reliable space-time jumps in risk of long latency chronic
disease such as cancers. Thus, we assume a simple exchangeable hierarchical
structure for the interaction terms ηij Oleson et al. (2008), Richardson et al.
(2006).
2.4 Computation and model comparison
In oder to estimate the parameters, we employ Markov Chain Monte Carlo
(MCMC) techniques, using the software WinBUGS Spiegelhalter et al. (2002).
Posterior inference is based on a total of 50,000 simulated draws keeping every
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Table 1: Registered numbers of cancers in 2004-2008
Year 2004 2005 2006 2007 2008 Total
Esophagus 2584 3046 3176 3164 3859 15829
Stomach 5209 5836 5903 6235 7710 30893
Bladder 3301 3936 4053 4417 4833 20540
Colorectal 3407 4056 4493 4887 6178 23021
Lung 1508 1788 1922 2066 3048 10332
Prostate 2072 2722 2815 3164 3732 14505
Breast 4683 5981 6675 7192 8589 33120
10th, after discarding the first 20,000 iterations as a burn-in sequence. To assess
the convergence of our MCMC sampler, we use the diagnostics of Gelman and
Rubin (1992) as well as graphical checks of the sample paths. Also, to produce
the maps we use geographical information system (GIS).
Models comparison is done via the Deviance Information Criterion (DIC).
DIC is computed as sum of deviance D¯ and number of effective parameters pD.
The deviance is the Bayesian model fit, computed as the estimated expected
posterior of minus two times log-likelihood of the observed data. Hierarchical
models always have a high number of (correlated) parameters. However, due to
the correlation between parameters, the true complexity is usually much lower,
for examples when parameters are estimated to be zero, i.e., are not needed in
the model. The number of effective parameters pD is an estimate of the number
of parameters effectively used in the model, that is, it estimates the complexity
of the model. More details can be found in (Spiegelhalter et al., 2002).
3 Results
Table 1 provides a brief summary of the data on incidence of the seven considered
cancers in each year. Among the seven cancers considered in this study, the most
and least common cancers were breast and lung cancers.
In Table 2 model comparison criteria for the four models and also for the
multivariate spatial shared component are presented. The first column of the ta-
ble D¯ can be considered as a Bayesian measure of fit gives the expectation of the
posterior deviance. The second column pD is the number of effective parameters
and can be considered as a measure of complexity. Among the models, Model A
had the poorest overall fit and the lowest complexity. Great improvements in the
DIC values are seen by including heterogeneity or space-time interaction param-
eters. Model D, which includes both space-time interaction and heterogeneity
terms has the best absolute model fit, but at the expense of many more effec-
tive parameters. Interestingly, this model has more effective parameters than
the model B resulting in a slightly larger DIC. This suggests that the hetero-
geneity and interaction terms are competing to explain the spacetime structure
not captured by the main effects. For reasons of brevity, we only present maps
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Table 2: DIC, D¯ and pD for all models.
Model D¯ pD DIC
Model A: no interaction + no heterogeneity 13327.40 119.01 13446.40
Model B: heterogeneity 7318.99 764.68 8083.67
Model C: interaction 7360.73 788.166 8148.90
Model D: interaction + heterogeneity 7314.78 774.97 8089.75
Spatial shared component model 7318.54 891.96 8210.49
and graphs resulting from model B. In Table 2 we also reported sum of the DIC
values from the corresponding multivariate spatial shared component model in
each year. This model was worse than all the models except model A. This
suggested that the model can indeed be improved by considering the temporal
structure of the data.
The map of the smoothed RRs for the cancers corresponding to model B is
presented in Fig. 1. The maps for other cancers are available in the online ap-
pendix. According to the maps for esophagus and stomach cancers the northern
part of Iran was the area of high risk. For bladder cancer Gilan, Semnan, Fars,
Isfahan, Yazd and Eastern Azerbaijan were found as the provinces with higher
risk. For bladder and lung cancer, the areas with higher risk were the north-
west. For prostate and breast cancers, Isfahan, Yazd, Fars, Tehran, Semnan,
Mazandaran and Razavi Khorasan were recognized as the areas with higher risk.
The estimated effects of the four shared spatial components λl are mapped
in Fig. 2. The component A, shared by esophagus, stomach, bladder and lung,
can be considered to represent the effect of smoking and had more effect in Gi-
lan, Mazandaran, Chaharmahal and Bakhtiari, Kohgilouyeh and Boyerahmad,
Ardebil and Tehran provinces respectively. Component B, sharied by esophagus,
colorectal, prostate and breast cancers can be considered to represent the effect
of overweight and obesity. For this component the largest effect was found for
Tehran, Razavi Khoasan, Semnan, Yazd, Isfahan, Fars, Mazandaran and Gilan,
respectively. The component C is shared by esophagus and stomach cancers
and is considered to represent the effect of inadequate fruit and vegetable con-
sumption. It did not show any significant differences among the provinces. For
the component D, shared by colorectal and breast cancers and considered to
represent the effect of low physical activity, North Khorasan, Ardebil, Golestan,
Ilam, Razavi Khorasan and Southern Khorasan were found to have the largest
effects respectively.
Table 3 represents the temporal effect of the shared components. As ex-
pected, all relative risks in each time period were near 1 and none of them were
significant.
Table 4 shows the level of importance or relative weight δ, that each shared
component has for the spatial variation of the relevant cancers. The first com-
ponent (considered to represent smoking) is significantly more important for
7
Figure 1: Posterior median relative risk for esophagus cancer in Iran provinces
between 2004 and 2008
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Figure 2: Estimated relative risks for the spatial effects of the four components.
A (”smoking”): Shared component for esophagus, stomach, bladder and lung
cancer. B (”overweight”): Sharing for esophagus, colorectal, prostate and breast
cancer. C (”inadequate fruit/vegetables consumption”): Sharing for esophagus
and stomach. D (”low physical activity”): Sharing for colorectal and breast.
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Table 3: Estimated relative risks for the temporal effects of the four components
in each time period. Posterior median (95% CI) per year.
Component 2004 2005 2006 2007 2008
1 0.99 1.00 1.01 1.00 1.00
(0.94-1.05) (0.97-1.04) (0.98-1.05) (0.97-1.04) (0.94-1.04)
2 1.01 1.00 1.00 1.00 0.99
(0.96-1.06) (0.97-1.04) (0.97-1.03) (0.97-1.04) (0.94-1.03)
3 1.00 1.00 1.00 1.00 1.00
(0.95-1.06) (0.95-1.03) (0.96-1.03) (0.97-1.05) (0.95-1.05)
4 0.99 1.00 1.00 1.01 1.01
(0.93-1.04) (0.96-1.04) (0.96-1.03) (0.97-1.05) (0.96-1.06)
stomach than for esophagus, bladder and lung cancers. The effect of second
component (representing overweight and obesity) was significantly more for col-
orectal than of esophagus cancer. The two last components (representing low
physical activity and inadequate consumption of fruits and vegetables) did not
show any significant differences according to the weights on the relevant cancers.
The figures in the main body of the table represent the weight of the cancer
listed along the columns to the cancers listed along the rows (with 95% confi-
dence intervals). If the RR is greater than 1.00 the cancer along the columns
has more weight, if the RR is less than 1.00 the cancer along the rows has more
weight.
Table 5 shows the relative weight that each shared component has for the
temporal variation of the relevant cancers. None of the components shows sig-
nificant differences according to the weights on the temporal changes of the
relevant cancers.
4 Discussion
In this paper, we have combined the ideas of multivariate spatial shared com-
ponents and bivariate spatio-temporal shared component models. This way,
we have presented a novel and valuable model that is capable to include any
desired number of diseases, geographical areas, time periods and shared compo-
nents representing the risk factors.
The proposed models allows for better estimation of the spatial pattern and
of the temporal trend of the diseases by incorporating joint information from
multiple diseases. Additionally, fitting this latent variables model enables us to
estimate the effect of shared components representing the risk factors in all the
spatial areas and time periods without the need of having real data for these
factors. We also have the possibility to compare the relative weight of each
component for the spatial and temporal variations of its relevant diseases using
the scaling parameters.
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Our proposed model has benefits over the pure spatial shared component
models in addition to make improvement according to Deviance Information
Criterion (DIC) and model fit. The results illustrate the changes over time
by including temporal effects and hereby increasing the epidemiological inter-
pretability the results. The model allows to investigate the persistence of pat-
terns over time and highlight unusual patterns. In addition suitable spacetime
interaction terms can be included, allowing for the detection of localized clusters
and strengthening inference Richardson et al. (2006), Manda et al. (2009).
Our model also has some advantages over other multivariate spatio-temporal
models, mainy the ability to estimate the spatial and temporal effects of shared
components as surrogates of the risk factors. We can also estimate the relative
importance of each component on the relevant diseases through including the
spatial and temporal scaling parameters. It is oossible include different struc-
tures of spacetime, space-disease and disease-time interactions and to include
data on environmental, social, economical, etc. covariates Richardson et al.
(2006), Manda et al. (2009).
The final results will depend on the number of shared components represent-
ing the risk factors and their relevant diseases. So, using this model one needs
to define the relationship between the diseases and risk factors in advance. To
do so, we need to apply the epidemiological background of the diseases Downing
et al. (2008), Held et al. (2005). One constraint of our model is the indepen-
dency assumption between the shared components, and impossibility of assess-
ing the interactions among the covariates Knorr-Held and Best (2001), Held
et al. (2005), Best and Hansell (2009).
When observed numbers of diseases in each geographical area small, the
model has more strength in compare with mapping crude or standardized rates
or simple Besag/York/Mollie models. The smaller the areas the less the ob-
served counts and the better the estimates of our model Richardson et al. (2006),
Manda et al. (2009). Also, when information is available for more time periods,
our model should work better. With long latency diseases like cancers, investi-
gating the observed rates for lots of time period or for few long time periods such
as 5-year periods are ideal because we do not expect remarkable changes over a
short time period for cancer Richardson et al. (2006), Manda et al. (2009).
From an epidemiological point of view we found a clearer spatial pattern
with an obvious distinction between the high risk and low risk areas for the
stomach and esophagus cancers in comparison with other cancer types. In
comparison with less frequent cancers smaller changes over the time periods
were observed. We have found notable similarities between the geographical
patterns of the relative risks of esophagus and stomach cancers and also for
bladder and colorectal cancers and again for breast and prostate cancers. The
patterns for bladder and colorectal cancers are different from that of esophagus
and stomach cancers. The spatial pattern for the relative risk of lung cancer is
quite different from all others cancers.
Sistan and Baluchestan had the lowest relative risk for all the seven cancer
in all the time periods for. After this province, Hormozgan, North Khorasan,
South Khorasan, Kohgilouyeh and Boyerahmad, Kerman and Bushehr were
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found as the lowest risk areas respectively. Also, Razavi Khorasan, Semnan,
Gilan, Mazandaran, Yazd, Isfahan, East Azerbaijan, Fars, West Azerbaijan,
Kurdistan, Tehran, Ardebil and Golestan were recognized as the areas with
highest risks. These results are in accordance with the results of previous stud-
ies about incidence and prevalence of the cancers in provinces, and similarity
between the spatial patterns of the cancers Azadeh et al. (2008), Islami et al.
(2009), Mousavi et al. (2009), Sadjadi et al. (2003, 2010).
Temporal effects of the shared components representing the four latent risk
factors were almost constant. According to the type of disease and the short
and few time periods in this study, this was predictable. The result revealed
the need for further studies including more time periods. Due to the lack of
accurate data for cancer registration system in the county level, we considered
Iran provinces as geographical areas. Also, since the cancer registration has been
implemented in recent years, we restricted the data only for years 2004 to 2008.
Due to some unexplained dispersion in the model and also due to other possible
risk factors associated with the cancers, it would be helpful to include some
other components to the model or to add real data of some important variables
as ecological covariates. In this regard, adding socio-economic background as
an important factor for all cancers can be considered Dabney and Wakefield
(2005).
In summary our presented model is a valuable model to model geographi-
cal and temporal variation among diseases and has some interesting potential
features and benefits over other joint models.
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